Jul 11, 2024 / 11:00AM GMT
Stuart Gander - Q linea AB - Chief Executive Officer
Hello, and good afternoon, everyone. This is Stuart Gande here, CEO of Q-linea. I'm joined by my CFO, Christer Samuelsson, for Q-linea's Q2 report. So thank you for taking the time to join us.
We'll do this similar to previous. I will make some opening comments, give you a general sense of where we are in the business and some of the highlights from the last quarter. And then I'll make -- I'll turn it over to Christer, who will walk us through the financials for the quarter.
So with that, just a quick flash or regular disclaimer here, so you've read that with respect to any forward-looking statements. A few of the key messages I wanted to make sure that you hear during our discussion today.
Number one, following the FDA approval at the end of April, we're now in full commercial push mode in the US. I'll speak to it more in detail, but obviously this is a very large market with a large opportunity for rapid AST. So we're being very thoughtful in terms of how we approach it and segment it. So we utilize our relatively small
Half Year 2024 Q linea AB Earnings Call Transcript
Jul 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers